MonumenTAL-6
64407564MMY3009: A Phase 3 Randomized Study Comparing Talquetamab in Combination With Pomalidomide (Tal-P), Talquetamab in Combination With Teclistamab (Tal-Tec), and Investigator's Choice of Either Elotuzumab, Pomalidomide, and Dexamethasone (EPd) or Pom
More Information
- Trial Status
- Accepting patients
- Trial Phase
- Phase 3
- Enrollment
- 795 patients (estimated)
- Sponsors
- Johnson & Johnson
- Tags
- Bispecific Antibody, GPRC5D, CD3, Randomization
- Trial Type
- Treatment
- Last Update
- SparkCures ID
- 1963
- NCT Identifier
- NCT06208150
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print a patient-friendly report to share with your patient.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.